• Publications
  • Influence
Multiple Sclerosis Severity Score
The Multiple Sclerosis Severity Score (MSSS) is a powerful method for comparing disease progression using single assessment data and can be used as a reference table for future disability comparisons.
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
Measurement of the combined local synthesis of antibodies against measles, rubella, and/or varicella zoster could represent a significant advance if it offers higher specificity (not sensitivity) for identifying chronic rather than acute inflammation.
The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population
The Brief Repeatable Battery of Neuropsychological Tests (BRB) is by far the most widely used instrument to estimate cognitive dysfunction in multiple sclerosis (MS) patients. However, the paucity of
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
It is confirmed that psychiatric comorbidity, particularly depression and anxiety, is common in MS, however, the incidence and prevalence remains understudied.
The prevalence of pain in multiple sclerosis
Comparison between different groups showed significant differences for age, Expanded Disability Status Scale, disease duration, and disease course, but not for sex, underlines the relevance of pain in the clinical history of MS.
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in people with multiple sclerosis (PwMS).
Cognitive and psychosocial features of childhood and juvenile MS
In childhood and juvenile cases, multiple sclerosis is associated with cognitive impairment and low IQ scores, the latter related to younger age at onset, which is of critical importance in helping children and adolescents with MS to manage their difficulties and psychosocial challenges.
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial
Although the program trained different attention components, it could detect some improvements exclusively on tasks of sustained attention, and patient self-perceived results may be independent of the training program.
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome
It is suggested that mitoxantrone might be effective in reducing disease activity, both by decreasing the mean number of exacerbations and by slowing the clinical progression sustained by most patients after 1 year from the end of treatment.